Published in Anticancer Res on April 03, 2008
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer (2011) 1.53
MicroRNAs in ovarian carcinomas. Endocr Relat Cancer (2010) 1.25
Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res (2012) 1.19
MicroRNAs in prostate cancer. Prostate Int (2012) 0.96
Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer. Int J Med Sci (2008) 0.88
Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Mol Cancer (2017) 0.75
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol (2005) 3.15
Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol (2004) 3.06
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol (2009) 2.41
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol (2008) 2.37
Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol (2007) 2.30
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol (2006) 2.15
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer (2005) 2.15
Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol (2007) 2.09
Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc Natl Acad Sci U S A (2007) 1.87
Prognostic value of thrombocytosis in renal cell carcinoma. J Urol (2006) 1.87
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol (2011) 1.87
Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma. J Urol (2009) 1.83
A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol (2008) 1.77
Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol (2007) 1.67
Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol (2005) 1.58
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol (2004) 1.52
Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol (2007) 1.51
Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study. Inflamm Bowel Dis (2013) 1.49
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer (2007) 1.43
Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress. Mol Vis (2009) 1.39
Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia (2005) 1.31
Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J Pharmacol Exp Ther (2003) 1.30
Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol (2006) 1.27
Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol (2012) 1.23
New insights in mucosal vaccine development. Vaccine (2011) 1.23
Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. Biochim Biophys Acta (2002) 1.22
Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int (2007) 1.19
Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. Brain Res Mol Brain Res (2004) 1.18
The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell (2009) 1.14
Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur J Cancer (2010) 1.13
Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer (2007) 1.11
Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2011) 1.11
Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol (2007) 1.08
Macrophages from cancer patients: analysis of TRAIL, TRAIL receptors, and colon tumor cell apoptosis. J Natl Cancer Inst (2003) 1.07
Extracellular release of ATP mediated by cyclic mechanical stress leads to mobilization of AA in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2009) 1.07
Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol (2007) 1.06
Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions. Clin Cancer Res (2005) 1.06
Alterations in gene expression induced by cyclic mechanical stress in trabecular meshwork cells. Mol Vis (2009) 1.06
Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol (2008) 1.05
Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction. J Leukoc Biol (2005) 1.05
Cultured porcine trabecular meshwork cells display altered lysosomal function when subjected to chronic oxidative stress. Invest Ophthalmol Vis Sci (2008) 1.04
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy. Can Urol Assoc J (2008) 1.03
Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol (2009) 1.02
Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells. Mol Vis (2009) 1.00
Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. J Immunol (2004) 1.00
Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol (2004) 0.98
Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol (2008) 0.98
Unclassified renal cell carcinoma: an analysis of 85 cases. BJU Int (2007) 0.98
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic. Proc Natl Acad Sci U S A (2008) 0.98
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. Eur Urol (2007) 0.98
MicroRNA-24 regulates the processing of latent TGFβ1 during cyclic mechanical stress in human trabecular meshwork cells through direct targeting of FURIN. J Cell Physiol (2011) 0.98
Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database. Urology (2005) 0.97
Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c. PLoS One (2012) 0.97
Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells. J Gene Med (2006) 0.96
Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis. Inflamm Bowel Dis (2014) 0.96
Malignant Langerhans cell tumor: a case with a favorable outcome associated with the absence of blood dendritic cell proliferation. J Am Acad Dermatol (2003) 0.95
Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells. PLoS Biol (2013) 0.95
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy. Cancer (2008) 0.94
LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma. Mol Vis (2010) 0.93
A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. J Urol (2007) 0.92
Primary central nervous system lymphoma: immunohistochemical profile and prognostic significance. Neuropathology (2009) 0.91
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol (2009) 0.89
Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma. Eur Urol (2010) 0.89
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma. BJU Int (2008) 0.89
Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells. Biomaterials (2010) 0.88
Surface geometric and electronic structures of BaFe2As2(001). Phys Rev Lett (2009) 0.88
Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol (2004) 0.88
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer (2005) 0.88
HIV-1 infection of Langerhans cells in a reconstructed vaginal mucosa. J Infect Dis (2004) 0.88
Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy. BJU Int (2009) 0.87
Selective sequestration of X4 isolates by human genital epithelial cells: Implication for virus tropism selection process during sexual transmission of HIV. J Med Virol (2005) 0.87
Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol (2006) 0.87
[Complications and medium-term functional results of TVT in stress urinary incontinence]. Prog Urol (2003) 0.86
[Varicocele and male infertility: AFU 2006 guidelines]. Prog Urol (2007) 0.86
Tissue compartment analysis for biomarker discovery by gene expression profiling. PLoS One (2009) 0.85
Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties. J Control Release (2013) 0.85
A flow cytometry technique to study nuclear factor-kappa B (NFkappaB) translocation during human B cell activation. Immunol Lett (2003) 0.85
Testosterone Deficiency Syndrome (TDS) needs to be named appropriately--the importance of accurate terminology. Eur Urol (2006) 0.85
CA9 as a molecular marker for differential diagnosis of cystic renal tumors. Urol Oncol (2010) 0.85
Persistent oligoclonal CD4dimCD8+T cells in peripheral blood. Cytometry B Clin Cytom (2005) 0.85
Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors. Cell Oncol (2005) 0.85
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer (2007) 0.85
Effects of resveratrol on longevity, cognitive ability and aging-related histological markers in the annual fish Nothobranchius guentheri. Exp Gerontol (2012) 0.84
Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics. Urology (2009) 0.84
CD3 bright lymphocyte population reveal gammadelta T cells. Cytometry B Clin Cytom (2004) 0.84
Identification of germinal center B cells in blood from HIV-infected drug-naive individuals in Central Africa. Clin Dev Immunol (2004) 0.84
Testicular sperm extraction in a single cancerous testicle in patients with azoospermia: a case report. Fertil Steril (2007) 0.84